Patentable/Patents/US-7795379
US-7795379

Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

PublishedSeptember 14, 2010
Assigneenot available in USPTO data we have
Inventorsnot available in USPTO data we have
Technical Abstract

The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.

Patent Claims

Legal claims defining the scope of protection, as filed with the USPTO.

Claim text for this patent isn't available yet.

Classification Codes (CPC)

Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.

G01N
Patent Metadata

Filing Date

September 6, 2005

Publication Date

September 14, 2010

Want to explore more patents?

Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.

Browse All PatentsTry Prior Art Search
Citation & reuse

Analysis on this page is generated by Patentable — an AI-powered patent intelligence platform. AI-generated summaries, explanations, and analysis may be reused with attribution and a visible link back to the canonical URL below. Patent abstracts and claims are USPTO public domain.

Cite as: Patentable. “Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof” (US-7795379). https://patentable.app/patents/US-7795379

© 2026 Patentable. All rights reserved.

Patentable is a research and drafting-assistant tool, not a law firm, and does not provide legal advice. Documents we generate are drafts for review by a licensed patent attorney.